MASLD-HCCMetabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma (MASLD-HCC)sorafeniblenvatinibfirst-line therapy
…temic delivery of CD133-siRNA nanoparticles potently sensitised MASLD-HCC to sorafenib and lenvatinib, significantly improving outcomes i…